Yurika Sugita

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis

Hirofumi Yamamoto, Motoi Kondo, Shoji Nakamori et al. · Gastroenterology · 2003 · 124 citations

Veterinary Medicine, Pharmacology, Cell Signaling +13

NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors

Yurika Sugita, Hisashi Wada, Shoichiro Fujita et al. · Cancer Research · 2004 · 98 citations · Full text

Medicine, Oncology, Pathology +15

Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay

Yoshihiro Okada, Yoshiyuki Fujiwara, Hirofumi Yamamoto et al. · Cancer · 2001 · 87 citations · Full text

Medicine, Oncology, Pathology +17

NY-ESO-1 Expression and Immunogenicity in Esophageal Cancer

Shoichiro Fujita, Hisashi Wada, Achim A. Jungbluth et al. · Clinical Cancer Research · 2004 · 72 citations

Medicine, Immunology, Oncology +17

Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.

Itsuro Sohma, Yoshiyuki Fujiwara, Yurika Sugita et al. · PubMed · 2011 · 69 citations

Medicine, Oncology, Pharmacology +12